Michael P. Stehn
Corporate Officer/Principal bij Parenteral Drug Association
Profiel
Michael P.
Stehn is a Member of the Parenteral Drug Association.
He was previously the Director of Quality Assurance & Regulatory Compliance at The Rugby Group, Inc. and the Senior Vice President of Operations at Akorn, Inc. from 1990 to 2020.
He obtained an undergraduate degree from Fairleigh Dickinson University.
Currently, Mr. Stehn holds a job at Parenteral Drug Association.
Actieve functies van Michael P. Stehn
| Bedrijven | Functie | Begin |
|---|---|---|
| Parenteral Drug Association | Corporate Officer/Principal | - |
Eerdere bekende functies van Michael P. Stehn
| Bedrijven | Functie | Einde |
|---|---|---|
| AKORN, INC. | Operationeel Directeur | 05-09-2012 |
The Rugby Group, Inc.
 The Rugby Group, Inc. Pharmaceuticals: MajorHealth Technology Part of AbbVie, Inc., The Rugby Group, Inc. is a company that develops and manufactures generic drugs. The company is based in Parsippany, NJ. The Rugby Group was acquired by Actavis, Inc. from Hoechst AG on August 26, 1997 for $70 million. | Corporate Officer/Principal | - |
Opleiding van Michael P. Stehn
| Fairleigh Dickinson University | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 3 |
|---|---|
Akorn, Inc.
 Akorn, Inc. Pharmaceuticals: MajorHealth Technology Akorn, Inc. engages in the development, manufacture, and marketing of generic and prescription pharmaceuticals, and animal and consumer health products. It manufactures and markets branded and generic products including ophthalmic, injectable, oral liquids, topical, inhalants, and nasal sprays. The company was founded in 1971 and is headquartered in Lake Forest, IL. | Health Technology |
The Rugby Group, Inc.
The Rugby Group, Inc. Pharmaceuticals: MajorHealth Technology Part of AbbVie, Inc., The Rugby Group, Inc. is a company that develops and manufactures generic drugs. The company is based in Parsippany, NJ. The Rugby Group was acquired by Actavis, Inc. from Hoechst AG on August 26, 1997 for $70 million. | Health Technology |
| Parenteral Drug Association |